VTGN•prnewswire•
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Summary
NEW YORK, Jan. 19, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. (NASDAQ: VTGN) and certain of its officers. This lawsuit seeks to recover...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 19, 2026 by prnewswire